Related Experiment Video
Updated: Nov 18, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Managing multiple myeloma during COVID-19: an ongoing saga
Angel López-Candales1, Pankaj Mathur2, Jack Xu2
1Cardiovascular Medicine Division, Truman Medical Center, University of Missouri-Kansas City, Kansas, MO, USA.
No abstract available in PubMed .
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Treatment Resistant Cancers
Chronic Kidney Disease IV: Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Kidney Transplant III: Nursing Management